Clinical trials use Sleeping Beauty gene transfer to create CAR T cells
The first clinical trials using the Sleeping Beauty gene transfer system
to customize immune system T cells to attack specific types of leukemia
and lymphoma indicate the approach to be safe and feasible,
investigators reported at the 55th American Society of Hematology (ASH)
Annual Meeting and Exposition.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Clinical Trials | Genetics | Hematology | Leukemia | Lymphoma